Global Colloids (Blood Plasma) Market Growth 2025-2031

The global Colloids (Blood Plasma) market size is predicted to grow from US$ 378 million in 2025 to US$ 323 million in 2031; it is expected to grow at a CAGR of -2.6% from 2025 to 2031.

Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.

Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.

North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.

The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.

LP Information, Inc. (LPI) ' newest research report, the “Colloids (Blood Plasma) Industry Forecast” looks at past sales and reviews total world Colloids (Blood Plasma) sales in 2024, providing a comprehensive analysis by region and market sector of projected Colloids (Blood Plasma) sales for 2025 through 2031. With Colloids (Blood Plasma) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Colloids (Blood Plasma) industry.

This Insight Report provides a comprehensive analysis of the global Colloids (Blood Plasma) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Colloids (Blood Plasma) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Colloids (Blood Plasma) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Colloids (Blood Plasma) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Colloids (Blood Plasma).

This report presents a comprehensive overview, market shares, and growth opportunities of Colloids (Blood Plasma) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Natural Type Colloids (Blood Plasma)
Synthetic Type Colloids (Blood Plasma)

Segmentation by Application:
Extensive Burns
Massive Blood or Plasma Loss
Hypovolemic Shock
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
CSL Behring
Baxter
Grifols
Octapharma
Kedrion
Shanghai Raas
CTBB
Hualan Bio
Rongsheng Pharmaceutical
Boya Rongsheng
B. Braun Medical
Fresenius Kabi
HOSPIRA
Axa parenterals
Fresenius Kabi (China)
CR Double-Crane
Kelun Group
Shandong Qidu Pharmaceutical
Shandong Hualu Pharmaceutical
Minsheng Pharma
Kanglepharm

Key Questions Addressed in this Report

What is the 10-year outlook for the global Colloids (Blood Plasma) market?

What factors are driving Colloids (Blood Plasma) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Colloids (Blood Plasma) market opportunities vary by end market size?

How does Colloids (Blood Plasma) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.